Human immunodeficiency virus (HIV) infection remains an ongoing problem and a key public health interest. Experts are interested in finding the best strategies for HIV prevention, including the best ...
HIV New Injection Trial: Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV infection for 12 months. In the stage 1 clinical trial, ...
Share on Pinterest Lenacapavir is a twice-yearly injection to prevent HIV that could improve adherence rates compared to other PrEP medications. d3sign/Getty Images The WHO issued a global ...
The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV — a milestone that the company and some experts say could help bring the world ...